December 27, 2013 / 7:21 AM / 4 years ago

BRIEF-AstraZeneca and Shionogi extend Crestor licence

1 Min Read

Dec 27 (Reuters) - AstraZeneca PLC : * And shionogi settle arbitration and extend licence agreement for crestor * Under the revised terms of the agreement, royalty payments from AstraZeneca to Shionogi has been modified to reduce the effective royalty rate in 2014-2015; the amount of this royalty rate reduction will be a low single-digit number * Agreement will extend the period of royalty payments from 2016 to 2023 * Source text for Eikon: * For more news, please click here

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below